Citation
(2009), "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials", Clinical Governance: An International Journal, Vol. 14 No. 4. https://doi.org/10.1108/cgij.2009.24814dae.004
Publisher
:Emerald Group Publishing Limited
Copyright © 2009, Emerald Group Publishing Limited
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 14, Issue 4
Antithrombotic Trialists’ (ATT) Collaboration,Lancet,2009,Vol. 373,pp. 1849-1860,
This review concluded that the use of aspirin for the prevention of cardiac events needed to be weighed against an increase in major bleeds. There was no justification in advocating the routine use of aspirin. Despite some concerns, the analyses contained a large number of people and the results seemed consistent. The conservative conclusions were likely to be reliable.